Oct 16th Plymouth Medical Webinar covering Basic PRP science, the need for PRP classification and a review of hematological results from our self funded side by side PRP analysis comparing Magellan, Selphyl, Eclipse, EmCyte Gold, EmCyte PurePRP and Regenlab PRP. PRP Dose, PRP system Efficiency and PRP Purity were all characterized with Plymouth Medical's hemocytomer, the Micros ES60.
The results are presented by Dr Jeremy Magalon. Dr Magalon is Medical Biologist specialized in Cell Therapy in France. He holds a university degree in Regenerative Medicine and a MSc in Tissue, Cell and Gene biotherapies. During his residency, he principally worked on autologous Platelet Rich Plasma (PRP) therapy and hemoglobinopathy. Since October 2017, he coordinates the fabrication of all PRP injections of Marseille University Hospital for use in different medical fields.
Dr Magalon is author of more than 30 papers and 2 book chapters in regenerative medicine, and has been speaker at more than 30 national and international congresses and courses.
His team’s publication in the British Medical Journal SEM in 2015 proposed a specific DEPA classification system for PRP systems to better help clinicians selecting a system that meets their specific needs for given indications.
Reference: Magalon J, Chateau AL, Bertrand B, et al DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices BMJ Open Sport & Exercise Medicine 2016;2:e000060. doi: 10.1136/bmjsem-2015-000060
10 июн 2020
